Chimerix will evidently have no trouble finding the 20 patients it is recruiting for the pilot study of its antiviral brincidofovir. And it still isn’t willing to provide its therapy under the FDA’s “compassionate use” regulations.

…read more

Source: Chimerix started the week as a punching bag, then pulls off a TKO


0 No comments